UTIAMC UTI AMC Q4 FY26 results (Jan–Mar 2026) and concall
UTI AMC reported a resilient Q4 and FY26, marked by strong AUM growth, significant new investor additions, and robust SIP contributions. The company achieved substantial efficiency gains through digital transformation and maintained a high dividend payout. However, consolidated profitability saw a decline, and employee costs rose due to strategic investments. The international business faced macro-economic headwinds, and equity net flows remained negative, prompting a strategic focus on SIP growth and product diversification.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 0.0%, net profit down 72.6% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 329 | 317 | 437 | 390 | 423 +29% | 317 +0% |
| EBITDA | 200 | 181 | 297 | 207 | 280 +40% | 64 −65% |
| Net profit | 142 | 124 | 216 | 166 | 124 −13% | 34 −73% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
